The Ireland-U.S. Council in America have this week presented the founder of healthcare diagnostics company Randox Laboratories with an award marking significant achievement in building relations between Northern Ireland and America.
With more than 1400 employees of 44 nationalities, including 300 research scientists and engineers, with offices and distribution in over 145 countries, Dungloe in Co Donegal is one of four key manufacturing and research and development sites, located in Ireland.
Presented to Dr Peter FitzGerald at the 56th Annual Dinner of the Ireland-U.S. Council yesterday evening, the accolade, named the Cúchulainn award, recognises the efforts of individuals who go above and beyond to support the objectives of the Ireland-U.S. Council – to improve the business bonds and commercial connections between Ireland, Northern Ireland and the United States.
Joining an exclusive line-up of some of the most prominent business figures in both Ireland and the United States recognised by the Ireland-U.S. Council, including CEO of International Airlines Group William Walsh, Dr FitzGerald was presented with the prestigious award at The Metropolitan Club in New York City.
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“I am most honoured to be here this evening to accept the Cúchulainn award from the Ireland-U.S. Council in recognition of the work undertaken by Randox in the United States since the early 1980s when we began to export our diagnostic healthcare products. The United States remains one of Randox’s most important markets, in which we are growing at pace thanks to the ongoing development of innovative new products in not only the healthcare sector, but also the veterinary, research, toxicology and food safety industries.”
The Ireland-U.S. Council was founded in 1962 by a group of American and Irish business leaders as a measure to build an established structure which would encourage closer economic relations, and was initially created to assist in making preparations for the first-ever State Visit of a sitting U.S. President to Ireland by President John F. Kennedy from June 26 – 29 in 1963.
David O’Sullivan, Executive Director of the Ireland–U.S. Council, added;
“Ever since the State Visit to Ireland by President John F. Kennedy, the Ireland-U.S. Council has been engaged in efforts to achieve our transatlantic mission. Dr FitzGerald of Randox Laboratories truly embodies the essence of this mission by aligning his business in Ireland closely with businesses in the US, to maximise the positive outcomes for both parties. We are delighted to present him this evening with the Cúchulainn award – for the significant contributions he has made to the development of closer economic, business and commercial ties between our two nations.”
Randox is a global leader in healthcare diagnostics; today more than 5% of the world’s population – in excess of 370 million people across 145 countries – receives medical diagnosis using Randox products each year. Randox is the largest diagnostic company from the UK and exports over 95% of products worldwide. Our products and services are used in hospitals, clinical, research and molecular laboratories, food testing, forensic toxicology, life sciences, and veterinary laboratories.
Main Caption: (pictured left to right) Dennis Swanson, former Ireland-US Council President; Brian Stack, President of the Ireland-US Council; Dr. Peter FitzGerald, Chief Executive and Founder Randox Laboratories; and John Reilly, Vice President Ireland-US Council.
If you have a story or want to send a photo or video to us please contact the Donegal Now editorial team. Between 9am and 5pm Monday to Sunday please call 074 9112712. Between 5pm and midnight please call or text 086 792 2103. Or you can email [email protected] at any time.